Yervoynew

807,56 

Therapeutic CTLA4-antibody from the original commercial drug Yervoy targeting the CTLA4-antigen (CD152), also referred to as Iplimumab antibody. This antibody is available with the original certificate of analysis (CoA).

Category Product Concentration [mg/mL] Volume per Vial [µL] Quantity per vial [mg] Batch Number Expiry date Availability Certificate of Analysis (CoA) PriceQuantityTotal
aliquot 54002ABE046808/20214 wksYes 807,56 
-
+
807,56 
spinner

Category: SKU: N/A

Description

Additional information

Weight N/A
Category

aliquot, dilution

Therapeutic molecule

Ipilimumab

Antigen

CD152, CTLA4

Product Concentration [mg/mL]

5

Volume per Vial [µL]

400

Quantity per vial [mg]

2

Batch Number

ABE0468

Manufacturing Year

2019

Expiry date

08/2021

Availability

4 wks

Certificate of Analysis (CoA)

Yes, No

You may also like…